CELG

Stock Market Today: The Deals Are Getting Done

By Bret Kenwell, InvestorPlace Contributor
Charles Schwab to purchase TD Ameritrade? Let's look at all of the M&A news making noise in the stock market today.

5 Healthcare Stocks to Buy

By William Roth, InvestorPlace Market Strategist
Healthcare in particular is one such sector, with a number of large-cap biotechnology and pharmaceutical stocks enjoying fresh rallies.

10 Great Biotech Stocks to Buy in Q4

By Sarah Smith, Editor-in-Chief, InvestorPlace.com
With FDA Breakthrough Therapy designations and robust drug pipelines, these biotech companies are all stocks to buy for 2020.

7 Big Biotech Stocks to Watch

By Chris Lau, InvestorPlace Contributor
Biotech stocks are still out of favor because of macro uncertainties. But beneath that, investors may find companies trading at deep value.

4 Biotech Stocks to Buy That Are on the Move

By William Roth, InvestorPlace Market Strategist
Biotech stocks overall are holding up fairly well amid recent market volatility. Look at which four biotech stocks to buy have staying power.

Amgen to Buy Celgene’s Otezla for $13.4B: Is the Deal Good for Amgen Stock?

By
Amgen's purchase of Celgenes blockbuster psoriasis drug, Otezla is likely to strengthen its position in the immunology space and boost Amgen stock.

Stock Market Today: Biotech in Focus, Trade Talks Steady Stocks

By Bret Kenwell, InvestorPlace Contributor
Trade talks gave a lift to stocks, while Johnson & Johnson will be in focus after the close. Here's what happened in the stock market today.

Celgene News: CELG Stock Jumps on Sale of Otezla to Amgen

By William White, InvestorPlace Writer
Celgene news for Thursday about it selling Otezla has CELG stock on the rise as it moves forward with the Bristol-Myers Squibb merger.

Fear Around Bristol-Myers Squibb Stock is Starting to Fade

By James Brumley, InvestorPlace Feature Writer
BMY stock may continue to bounce around, but the months-long selloff is now slowing because Bristol-Myers Squibb is still thriving.

Stock Market Today: Boeing, Tesla Tumble on More Worries

By Bret Kenwell, InvestorPlace Contributor
Stock were hit on Thursday as investors try to parse through a deluge of earnings results. Here's what moved the stock market today.

Why Bristol-Myers Squibb Stock Is Stumbling Ahead of Earnings

By Chris Lau, InvestorPlace Contributor
Investors turned sour on BMY stock after the Celgene buyout. Will a solid Q2 earnings report change the sentiment for the better?

Nasdaq Today: Biotech Wrecked; Buy Microsoft? 

By Bret Kenwell, InvestorPlace Contributor
Investors saw new highs in the Nasdaq today, but the index finished slightly lower on the day. Here's what we're watching now.

Nasdaq Today: Semis Rally, Micron Earnings, Suing FB and GOOGL?

By Bret Kenwell, InvestorPlace Contributor
Trump says that Facebook and Alphabet should be sued, while Micron surged on earnings. Semiconductors got a big boost in the Nasdaq today as well.

The Top 8 Tech Stocks of 2019 (So Far)

By Luke Lango, InvestorPlace Senior Investment Analyst
The stock market is off to its best year since 1997, and these tech stocks are leading that record rally. Here's what you should know.

5 Top Stock Trades for Wednesday — AGN, ABBV, FDX, MSFT, BB

By Bret Kenwell, InvestorPlace Contributor
AbbVie is buying Allergan, FedEx and Blackberry are reporting earnings and Microsoft is on the move. Here are our top stock trades.

3 Big Stock Charts for Tuesday: MGM Resorts, Electronic Arts and Advance Auto Parts

By James Brumley, InvestorPlace Feature Writer
The stock charts of EA, AAP and MGM have run through the technical trading wringer in front of today's action.

Nasdaq Today: Celgene, Ulta, Caesars’ Buyout

By Bret Kenwell, InvestorPlace Contributor
Celgene and Bristol-Myers Squibb stocks took a hit, video games rallied and Caesars Entertainment entered into a $17.3 billion merger. Here's the Nasdaq Today report.

5 Top Stock Trades for Tuesday: CELG, BMY, CZR

By Bret Kenwell, InvestorPlace Contributor
Bristol-Myers Squibb, Celgene, Caesars Entertainment, Match Group and New Relic are our top stock trades for Tuesday.

Bristol-Meyers Squibb News: Why BMY Stock Is Falling Today

By William White, InvestorPlace Writer
Bristol-Meyers Squibb news for Monday has BMY stock taking a beating after announcing a delay to its merger deal with Celgene.
Load More